Intellect Neurosciences Inc. (fka ILNS)

[qotsa55]

Mkaiz, Intellect won't last long enough to have a lead drug candidate go into late phase 3 trials getting ready for fda approval. In fact I don't believe Intellect will make it through 2014. They need a buyout now. The Viopharma deal for OX1 (now Shire owns it, so its anybodys guess what they plan to do with it) only gives Intellect royalties if the drug were approved. The company is only operating now by dumping shares into the market to pay for its day to day operations. There will not be a partnership because there is no one to partner up with at Intellect. No CEO, CFO, or Scientific Officer. I think their CONJUMAB platform is there best bet to be bought out. It is ready to go into phase one trials for AMD and I think a large Pharma would be willing to risk a few bucks to buy it.